The headline for your blog gives the impression that epilepsy drugs are flat out cleared as far as increasing suicide risk.

But as I understand it, the study was actually only on people with bipolar disorder and the drugs are prescribed for a multitude of ailments on and off-label so I think the headline could potentially give many users the wrong message.

Again, I almost hate to even mention it because I can not say enough about your reporting, and I certainly know it was not intentional.

But before we leave that topic, I have a point to make.

Mann served as an expert for Glaxo in Paxil suicide cases. How is it that he presumably had access to the same studies as plaintiff’s experts, such as Joseph Glenmullen, who reported that in adult studies conducted with Paxil in the late 1980s, before it was ever approved, people on Paxil were 8 times more likely to become suicidal than people taking placebos.

How did Mann ever respond to that report, does anybody know? Grassley discussed it at length in the congressional record.

In fact, Grassley supposedly asked for an explanation from Glaxo and the FDA. Does anybody know what happened there?

Glaxo by the way, has been busy quietly settling suicide cases left and right once jury trials were set to begin.

I hear birth defect cases are being quietly settled as well. Surprise, surprise.

Bipolar, as defined today, is just the new “Disease De Jour” of the day…